Overall Survival Analyzer: A software tool to analyze genotyping and clinical data enriched with temporal events
暂无分享,去创建一个
Mario Cannataro | Giuseppe Agapito | Pietro Hiram Guzzi | Mariamena Arbitrio | Pierfrancesco Tassone | Pierosandro Tagliaferri | C. Botta | M. Cannataro | P. Guzzi | P. Tassone | P. Tagliaferri | Giuseppe Agapito | M. Arbitrio | C. Botta
[1] KyungMann Kim,et al. Contrasting treatment‐specific survival using double‐robust estimators , 2012 .
[2] Kenta Nakai,et al. PrognoScan: a new database for meta-analysis of the prognostic value of genes , 2009, BMC Medical Genomics.
[3] Aedín C. Culhane,et al. survcomp: an R/Bioconductor package for performance assessment and comparison of survival models , 2011, Bioinform..
[4] C. Benz,et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies , 2006, Molecular Cancer.
[5] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[6] Kay Nieselt,et al. Mayday - integrative analytics for expression data , 2010, BMC Bioinformatics.
[7] Mario Cannataro,et al. DMET-Analyzer: automatic analysis of Affymetrix DMET Data , 2012, BMC Bioinformatics.
[8] J. Mesirov,et al. GenePattern 2.0 , 2006, Nature Genetics.
[9] Mario Cannataro,et al. coreSNP: Parallel Processing of Microarray Data , 2014, IEEE Transactions on Computers.
[10] Baolin Wu,et al. Network-based Survival Analysis Reveals Subnetwork Signatures for Predicting Outcomes of Ovarian Cancer Treatment , 2013, PLoS Comput. Biol..
[11] A. Martínez-Torteya,et al. SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis , 2013, PloS one.
[12] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] Nikhil Wagle,et al. High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. , 2012, Cancer discovery.
[14] Mario Cannataro,et al. Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: A DMET microarray profiling study , 2011, Cancer biology & therapy.
[15] Shale Dames,et al. Next generation sequencing for clinical diagnostics-principles and application to targeted resequencing for hypertrophic cardiomyopathy: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology. , 2010, The Journal of molecular diagnostics : JMD.
[16] L. Feuk,et al. Detection of large-scale variation in the human genome , 2004, Nature Genetics.
[17] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] W. Haenszel,et al. Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.
[19] T G Clark,et al. Survival Analysis Part I: Basic concepts and first analyses , 2003, British Journal of Cancer.
[20] Ming Ouyang,et al. DNA microarray data imputation and significance analysis of differential expression , 2005, Bioinform..
[21] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[22] Mariamena Arbitrio,et al. BRCA1/2 genetic background-based therapeutic tailoring of human ovarian cancer: hope or reality? , 2009, Journal of ovarian research.